Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar Depression

NCT07644767 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Bipolar Depression

Interventions

DRUG: KET-AD
OTHER: Placebo

Sponsor

Neurocentrx Pharma Pty Ltd